Compare ACOG & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACOG | ARAY |
|---|---|---|
| Founded | 2000 | 1990 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 115.5M | 100.5M |
| IPO Year | N/A | 2007 |
| Metric | ACOG | ARAY |
|---|---|---|
| Price | $5.67 | $0.84 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $18.00 | $4.50 |
| AVG Volume (30 Days) | 76.2K | ★ 826.4K |
| Earning Date | 11-13-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,427,199.00 | ★ $450,902,000.00 |
| Revenue This Year | N/A | $3.82 |
| Revenue Next Year | $132.35 | $4.08 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.51 |
| 52 Week Low | $3.75 | $0.78 |
| 52 Week High | $11.54 | $2.95 |
| Indicator | ACOG | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 42.26 | 40.90 |
| Support Level | $5.20 | $0.79 |
| Resistance Level | $6.04 | $0.88 |
| Average True Range (ATR) | 0.44 | 0.05 |
| MACD | -0.08 | 0.01 |
| Stochastic Oscillator | 28.02 | 36.19 |
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.